Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
VTGN VistaGen Therapeutics
- 2.5000
- +0.2500+11.11%
Close Dec 20 16:00 ET
- 2.6000
- +0.1000+4.00%
Post 19:43 ET
69.61MMarket Cap-3.38P/E (TTM)
2.5500High2.2300Low992.99KVolume2.2500Open2.2500Pre Close2.41MTurnover5.47%Turnover RatioLossP/E (Static)27.84MShares5.860052wk High0.75P/B45.40MFloat Cap2.220052wk Low--Dividend TTM18.16MShs Float1889.9991Historical High--Div YieldTTM14.22%Amplitude1.6200Historical Low2.4230Avg Price1Lot Size
About VistaGen Therapeutics Company
Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia). The company was founded by H. Ralph Snodgrass and Gordon Keller on May 26, 1998 and is headquartered in South San Francisco, CA.
Company Profile
SymbolVTGN
Company NameVistaGen Therapeutics
Listing DateMay 11, 2016
Issue Price4.25
Founded1998
CEOMr. Shawn K. Singh, J.D.
MarketNASDAQ
Employees40
Fiscal Year Ends03-31
Address343 Allerton Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-577-3600
Websitehttp://www.vistagen.com
Company Executives
- Name
- Position
- Salary
- Shawn K. Singh, J.D.
- Chief Executive Officer and Director
- 947.92K
- Cynthia Lynn Anderson, C.P.A.
- Vice President and Chief Financial Officer
- 434.19K
- Joshua S. Prince, M.B.A.
- Chief Operating Officer
- 568.44K
- Reid G. Adler, J.D.
- Chief Corporate Development Officer and General Counsel
- 675.00K
- Margaret M. FitzPatrick
- Chairman of the Board
- 185.62K
- Ann M. Cunningham, M.B.A.
- Director
- 313.12K
- Mary L. Rotunno, J.D.
- Independent Director
- 128.12K
- Dr. Jerry B. Gin, M.B.A.,PhD
- Independent Director
- 128.12K
- Joanne Curley, PhD
- Independent Director
- 113.12K
- Jon S. Saxe, J.D.,L.L.M.
- Independent Director
- 129.37K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
